The routine use of the urinary pneumococcal antigen test in hospitalised patients with community acquired pneumonia has limited impact for adjustment of antibiotic treatment

Swiss Medical Weekly

Volumn 142, Issue , 2012, Pages

  Piso, Rein Jan ^a   Iven Koller, Dorothee ^a   Koller, Michael T ^b   Bassetti, Stefano ^a  

^a KANTONSSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Antibiotic prescription; Binax Now streptococcus pneumonia; Community acquired pneumonia; Urinary antigen testing

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; CEPHALOSPORIN; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS ANTIGEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

AGED; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; COST CONTROL; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; PRESCRIPTION; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; STREPTOCOCCUS PNEUMONIA; URINALYSIS; URINARY PNEUMOCOCCAL ANTIGEN TEST; CLINICAL PRACTICE; COMMUNICABLE DISEASE; HEALTH STATUS INDICATOR; ISOLATION AND PURIFICATION; PATHOLOGY; STATISTICS; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL; URINE;

AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HEALTH STATUS INDICATORS; HOSPITALS, TEACHING; HUMANS; INPATIENTS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PNEUMONIA, PNEUMOCOCCAL; STATISTICS AS TOPIC; STREPTOCOCCUS PNEUMONIAE;

EID: 84866269502     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2012.13679     Document Type: Article

References (25)

1. National center of health Statistics. health, united states, 2008. available at: www.cdc.gov/nchs/data/hus/hus08.pdf [Internet]; 2008.
2. Woodhead M. Community-acquired pneumonia in europe: Causative pathogens and resistance patterns. Eur Respir J Suppl. 2002;36:20s-7s. (Pubitemid 34774185)
3. Woodhead M. The european vision of community-acquired pneumonia. Semin Respir Cr Care Med. 2009;30(2):136-45.
4. Schuetz P, Albrich WC, Suter I, Hug BL, Christ-Crain M, Holler T, et al. Quality of care delivered by fee-for-service and DRG hospitals in switzerland in patients with community-acquired pneumonia. Swiss Med Wkly. 2011;141:w13228.
5. File TM,Jr, Marrie TJ. Burden of community-acquired pneumonia in north american adults. Postgrad Med. 2010;122(2):130-41.
6. Ramirez JA, Anzueto AR. Changing needs of community-acquired pneumonia. J Antimicrob Chemother. 2011;66(Suppl 3):iii3-9.
7. Feikin DR, Schuchat A, Kolczak M, Barrett NL, Harrison LH, Lefkowitz L, et al. Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health. 2000;90(2):223-9. (Pubitemid 30062674)
8. van Mens SP, Meijvis SC, Endeman H, van Velzen-Blad H, Biesma DH, Grutters JC, et al. Longitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of streptococcus pneumoniae than estimated by conventional methods alone. Clin Vaccine Immunol. 2011;18(5):796-801.
9. Johansson N, Kalin M, Tiveljung-Lindell A, Giske CG, Hedlund J. Etiology of community-acquired pneumonia: Increased microbiological yield with new diagnostic methods. Clin Infect Dis. 2010;50(2):202-9.
10. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious diseases society of America/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(Suppl 2):S27-72. (Pubitemid 46290553)
11. Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005;26(6):1138-80. (Pubitemid 41829947)
12. Hoffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, et al. Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. guidelines of the paul-ehrlich-society for chemotherapy, the german respiratory society, the german society for infectiology and the competence network CAPNETZ germany. Pneumologie. 2009;63(10):e1-68.
13. Mertz D, Koller M, Haller P, Lampert ML, Plagge H, Hug B, et al. Outcomes of early switching from intravenous to oral antibiotics on medical wards. J Antimicrob Chemother. 2009;64(1):188-99.
14. Kronenberg A, Zucs P, Droz S, Muhlemann K. Distribution and invasiveness of streptococcus pneumoniae serotypes in switzerland, a country with low antibiotic selection pressure, from 2001 to 2004. J Clin Microbiol. 2006;44(6):2032-8. (Pubitemid 43902149)
15. Marcos MA, Jimenez de Anta MT, de la Bellacasa JP, Gonzalez J, Martinez E, Garcia E, et al. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J. 2003;21(2):209-14.
16. Selickman J, Paxos M, File TM,Jr, Seltzer R, Bonilla H. Performance measure of urinary antigen in patients with streptococcus pneumoniae bacteremia. Diagn Microbiol Infect Dis. 2010 Mar 23.
17. Smith MD, Sheppard CL, Hogan A, Harrison TG, Dance DA, Derrington P, et al. Diagnosis of streptococcus pneumoniae infections in adults with bacteremia and community-acquired pneumonia: Clinical comparison of pneumococcal PCR and urinary antigen detection. J Clin Microbiol. 2009;47(4):1046-9.
18. Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: The key to pneumococcal disease. Lancet Infect Dis. 2004;4(3):144-54. (Pubitemid 38293138)
19. van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009;374(9700):1543-56.
20. Matta M, Kerneis S, Day N, Lescat M, Hoi AB, Varon E, et al. Do clinicians consider the results of binax NOW streptococcus pneumoniae urinary antigen to adapt antibiotic regimen in pneumonia patients? Clin Microbiol Infect. 2009 Oct 20.
21. Feldman C. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia. J Lab Clin Med. 2004;143(5):269-83. (Pubitemid 38586492)
22. Mettler J, Simcock M, Sendi P, Widmer AF, Bingisser R, Battegay M, et al. Empirical use of antibiotics and adjustment of empirical antibiotic therapies in a university hospital: A prospective observational study. BMC Infect Dis. 2007;7:21.
23. Signori LG, Ferreira MW, Vieira LC, Muller KR, Mattos WL. Sputum examination in the clinical management of community-acquired pneumonia. J Bras Pneumol. 2008;34(3):152-8.
24. Schouten JA, Hulscher ME, Natsch S, Kullberg BJ, van der Meer JW, Grol RP. Barriers to optimal antibiotic use for community-acquired pneumonia at hospitals: A qualitative study. Qual Saf Health Care. 2007;16(2):143-9. (Pubitemid 46596455)
25. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in the gambia: Randomised, double-blind, placebo-controlled trial. Lancet. 2005;365(9465):1139-46. (Pubitemid 40417563)